Efficacy and safety with >3 years of inotersen treatment for the polyneuropathy of hereditary transthyretin amyloidosis

被引:0
|
作者
Coelho, Teresa [1 ]
Whelan, Carol [2 ]
Conceicao, Isabel [3 ,4 ]
Brannagan, Thomas [5 ]
Wang, Annabel [6 ]
Polydefkis, Michael [7 ]
Dyck, Peter [8 ]
Plante-Bordeneuve, Violaine [9 ]
Berk, John [10 ]
Merlini, Giampaolo [11 ]
Obici, Laura [11 ]
Drachman, Brian [12 ]
Gorevic, Peter [13 ]
Schmidt, Hartmut [14 ]
Plana, Josep Maria Campistol [15 ]
Gamez, Josep [16 ]
Kristen, Arnt [17 ]
Mazzeo, Anna [18 ]
Narayana, Arvind [19 ]
Olugemo, Kemi [20 ]
Aquino, Peter [21 ]
Benson, Merrill [22 ]
Gertz, Morie [23 ]
机构
[1] Ctr Hosp Univ Porto, Dept Neurophysiol, Porto, Portugal
[2] Royal Free Hosp, Natl Amyloidosis Ctr, London, England
[3] CHULN, Hosp Santa Maria, Lisbon, Portugal
[4] Univ Lisbon, Dept Neurosci, Fac Med, Lisbon, Portugal
[5] Columbia Univ, Med Ctr, Peripheral Neuropathy Ctr, New York, NY USA
[6] Univ Calif Irvine, Dept Neurol, Orange, CA 92668 USA
[7] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA
[8] Mayo Clin, Peripheral Nerve Res Lab, Rochester, MN USA
[9] CHU Henri Mondor, Dept Neurol, Creteil, France
[10] Boston Univ, Amyloidosis Ctr, Boston, MA 02215 USA
[11] IRCCS Fdn Policlin San Matteo, Amyloidosis Ctr, Pavia, Italy
[12] Penn Presbyterian Med Ctr, Dept Cardiovasc Med, Philadelphia, PA USA
[13] Mt Sinai Med Ctr, Dept Rheumatol, New York, NY 10029 USA
[14] Muenster Univ Hosp, Dept Gastroenterol Hepatol Endocrinol Diabetol &, Munster, Germany
[15] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, Hosp Clin, Barcelona, Spain
[16] Hosp Univ Vall dHebron, Dept Neurol, Barcelona, Spain
[17] Heidelberg Univ Hosp, Amyloidosis Ctr, Heidelberg, Germany
[18] Univ Messina, Dept Neurol, Messina, Italy
[19] Akcea Therapeut, Global Med Affairs, Boston, MA USA
[20] Akcea Therapeut, Clin Dev, Boston, MA USA
[21] Akcea Therapeut, Global Drug Safety & Pharmacovigilance, Boston, MA USA
[22] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA
[23] Mayo Clin, Bone Marrow Transplant Program, Rochester, MN USA
关键词
D O I
10.1016/j.jns.2021.117867
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
117867
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis
    Dyck, P. James B.
    Coelho, Teresa
    Waddington Cruz, Marcia
    Brannagan, Thomas H., III
    Khella, Sami
    Karam, Chafic
    Berk, John L.
    Polydefkis, Michael J.
    Kincaid, John C.
    Wiesman, Janice F.
    Litchy, William J.
    Mauermann, Michelle L.
    Ackermann, Elizabeth J.
    Baker, Brenda F.
    Jung, Shiangtung W.
    Guthrie, Spencer
    Pollock, Michael
    Dyck, Peter J.
    MUSCLE & NERVE, 2020, 62 (04) : 509 - 515
  • [22] Responsiveness of Neuropathy Symptom and Change (NSC) score components in inotersen treatment of hereditary transthyretin amyloidosis polyneuropathy
    Dyck, P. J. B.
    Coelho, T.
    Waddington Cruz, M.
    Brannagan, T.
    Khella, S.
    Karam, C.
    Berk, J. L.
    Polydefkis, M. J.
    Kincaid, J. C.
    Wiesman, J. F.
    Litchy, W. J.
    Mauermann, M. L.
    Ackermann, E. J.
    Baker, B. F.
    Jung, S. W.
    Guthrie, S.
    Pollock, M.
    Dyck, P. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 715 - 715
  • [23] Responsiveness of Neuropathy Symptom and Change (NSC) Score Components in Inotersen Treatment of Hereditary Transthyretin Amyloidosis Polyneuropathy
    Dyck, P. James B.
    Coelho, Teresa
    Cruz, Marcia Waddington
    Brannagan, Thomas
    Khella, Sami
    Karam, Chafic
    Berk, John L.
    Polydefkis, Michael J.
    Kincaid, John C.
    Wiesman, Janice F.
    Litchy, William
    Mauermann, Michelle L.
    Ackermann, Elizabeth J.
    Baker, Brenda F.
    Jung, Shiangtung W.
    Guthrie, Spencer
    Pollock, Michael
    Dyck, Peter J.
    NEUROLOGY, 2019, 92 (15)
  • [24] LONGTERM TREATMENT EFFECTS OF INOTERSEN ON QUALITY OF LIFE IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Brown, Duncan
    Karam, Chafic
    Yang, Min
    Done, Nicolae
    Zhu, JingJing
    Greatsinger, Ali
    Bozas, Ana
    Llonch, Montserrat Vera
    Signorovitch, James
    MUSCLE & NERVE, 2021, 64 : S57 - S57
  • [25] Hereditary Transthyretin Amyloidosis Polyneuropathy
    Qarni, Taha
    Moshe-Lilie, Orly
    Kaku, Michelle C.
    Karam, Chafic
    SEMINARS IN NEUROLOGY, 2025, 45 (01) : 75 - 87
  • [26] COST OF INOTERSEN AND PATISIRAN FOR THE TREATMENT OF ADULTS WITH POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS IN CANADA, GERMANY, AND ITALY
    Brown, D.
    Vera-Llonch, M.
    Shaff, M.
    Rolli, A.
    Vega, M.
    Blum, M.
    Nestler-Parr, S.
    Jiresch, M.
    Weycker, D.
    VALUE IN HEALTH, 2020, 23 : S606 - S607
  • [27] Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy
    Coelho, Teresa
    Marques, Wilson, Jr.
    Dasgupta, Noel R.
    Chao, Chi-Chao
    Parman, Yesim
    Franca, Marcondes Cavalcante, Jr.
    Guo, Yuh-Cherng
    Wixner, Jonas
    Ro, Long-Sun
    Calandra, Cristian R.
    Kowacs, Pedro A.
    Berk, John L.
    Obici, Laura
    Barroso, Fabio A.
    Weiler, Markus
    Conceicao, Isabel
    Jung, Shiangtung W.
    Buchele, Gustavo
    Brambatti, Michela
    Chen, Jersey
    Hughes, Steven G.
    Schneider, Eugene
    Viney, Nicholas J.
    Masri, Ahmad
    Gertz, Morie R.
    Ando, Yukio
    Gillmore, Julian D.
    Khella, Sami
    Dyck, P. James B.
    Cruz, Marcia Waddington
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (15): : 1448 - 1458
  • [28] Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis
    Teresa Coelho
    Aaron Yarlas
    Marcia Waddington-Cruz
    Michelle K. White
    Asia Sikora Kessler
    Andrew Lovley
    Michael Pollock
    Spencer Guthrie
    Elizabeth J. Ackermann
    Steven G. Hughes
    Chafic Karam
    Sami Khella
    Morie Gertz
    Giampaolo Merlini
    Laura Obici
    Hartmut H. Schmidt
    Michael Polydefkis
    P. James B. Dyck
    Thomas H. Brannagan III
    Isabel Conceição
    Merrill D. Benson
    John L. Berk
    Journal of Neurology, 2020, 267 : 1070 - 1079
  • [29] Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis
    Coelho, Teresa
    Yarlas, Aaron
    Waddington-Cruz, Marcia
    White, Michelle K.
    Kessler, Asia Sikora
    Lovley, Andrew
    Pollock, Michael
    Guthrie, Spencer
    Ackermann, Elizabeth J.
    Hughes, Steven G.
    Karam, Chafic
    Khella, Sami
    Gertz, Morie
    Merlini, Giampaolo
    Obici, Laura
    Schmidt, Hartmut H.
    Polydefkis, Michael
    Dyck, P. James B.
    Brannagan, Thomas H., III
    Conceicao, Isabel
    Benson, Merrill D.
    Berk, John L.
    JOURNAL OF NEUROLOGY, 2020, 267 (04) : 1070 - 1079
  • [30] An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Plante-Bordeneuve, Violaine
    Lin, Hollis
    Gollob, Jared
    Agarwal, Sonalee
    Betts, Marissa
    Fahrbach, Kyle
    Chitnis, Madhura
    Polydefkis, Michael
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (04) : 473 - 481